Frequency and specificity of antibodies against nuclear and cytoplasmic antigens in healthy individuals by classic and new methods

Clinical Rheumatology

Volumn 32, Issue 10, 2013, Pages 1541-1546

  Giannouli, E ^a   Chatzidimitriou, D ^b   Gerou, S ^a   Gavriilaki, E ^b   Settas, L ^a   Diza, E ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ANTINUCLEAR ANTIBODY; CYTOPLASM ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE; GENDER; GOLD STANDARD; HUMAN; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL;

ADULT; AGE FACTORS; ANTIBODIES; ANTIBODIES, ANTINUCLEAR; ANTIBODY SPECIFICITY; ANTIGENS; AUTOANTIBODIES; CELL NUCLEUS; CONNECTIVE TISSUE DISEASES; CYTOPLASM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEALTHY VOLUNTEERS; HUMANS; IMMUNOLOGIC TECHNIQUES; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84885229131     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-013-2284-5     Document Type: Article

References (22)

1. Peng SL, Hardin JA, Craft J (1997) Antinuclear antibodies. In: Kelly WN, Harris ED, Ruddy S, Sledge CB (eds) Textbook of rheumatology. WB Saunders, Philadelphia, p 250
2. Satoh M, Vázquez-Del Mercado M, Chan EK (2009) Clinical interpretation of antinuclear antibody tests in systemic rheumatic diseases. Mod Rheumatol 19:219-228. doi: 10.1007/s10165-009-0155-3
3. von Mühlen CA, Tan EM (1995) Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 24:323-358
4. Fritzler MJ, Pauls JD, Kinsella TD, Bowen TJ (1985) Antinuclear, anticytoplasmic, and anti-Sjogren's syndrome antigen A (SS-A/Ro) antibodies in female blood donors. Clin Immunol Immunopathol 36:120-128
5. Tan EM, Feltkamp TE, Smolen JS, Butcher B, Dawkins R, Fritzler MJ, Gordon T, Hardin JA, Kalden JR, Lahita RG, Maini RN, McDougal JS, Rothfield NF, Smeenk RJ, Takasaki Y, Wiik A, Wilson MR, Koziol JA (1997) Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum 40:1601-1611
6. Hilário MO, Len CA, Roja SC, Terreri MT, Almeida G, Andrade LE (2004) Frequency of antinuclear antibodies in healthy children and adolescents. Clin Pediatr (Phila) 43:637-642
7. Craig WY, Ledue TB, Johnson AM, Ritchie RF (1999) The distribution of antinuclear antibody titers in "normal" children and adults. J Rheumatol 26:914-919
8. Marin GG, Cardiel MH, Cornejo H, Viveros ME (2009) Prevalence of antinuclear antibodies in three groups of healthy individuals: blood donors, hospital personnel and relatives of patients with autoimmune diseases. J Clin Rheumatol 15:325-329. doi: 10.1097/RHU.0b013e3181bb971b
9. Fernandez SA, Lobo AZ, Oliveira ZN, Fukumori LM, Périgo AM, Rivitti EA (2003) Prevalence of antinuclear antibodies in the serum of normal blood donors. Rev Hosp Clin Fac Med Sao Paulo 58:315-319
10. Cunha LM, Bittencourt PL, Abrantes-Lemos CP, Moreira A, Parana R, Andrade Z (2012) Prevalence of non-organ specific autoantibodies in a rural community from northeastern Brazil: a population based study. Hum Immunol 73:70-74. doi: 10.1016/j.humimm.2011.10.001
11. Meroni PL, Schur PH (2010) ANA screening: an old test with new recommendations. Ann Rheum Dis 69:1420-1422. doi: 10.1136/ard.2009.127100
12. Fritzler MJ (1997). Immunofluorescent antinuclear antibody tests. In: American Society of Microbiology (ed) American manual of clinical laboratory immunology, Washington DC, pp: 920-927
13. National Institute for Biological Standards and Control, United Kingdom (2004) Instructions for use of antinuclear factor serum (homogeneous) human, NIBSC Code No: 66/233, Version 03
14. de Vlam K, De Keyser F, Verbruggen G, Vandenbossche M, Vanneuville B, D'Haese D, Veys EM (1993) Detection and identification of antinuclear autoantibodies in the serum of normal blood donors. Clin Exp Rheumatol 11:393-397
15. Makinodan T, Kay MM (1980) Age influence on the immune system. Adv Immunol 29:287-330
16. Lacroix-Desmazes S, Kaveri SV, Mouthon L, Ayouba A, Malanchère E, Coutinho A, Kazatchkine MD (1998) Self-reactive antibodies (natural autoantibodies) in healthy individuals. J Immunol Methods 216:117-137
17. Schulte-Pelcum J, Fritzler M, Mahler M (2009) Latest update on the Ro/SS-A autoantibody system. Autoimmun Rev 8:632-637. doi: 10.1016/j.autrev. 2009.02.010
18. Copple SS, Giles SR, Jaskowski TD, Gardiner AE, Wilson AM, Hill HR (2012) Screening for IgG antinuclear autoantibodies by HEp-2 indirect fluorescent antibody assays and the need for standardization. Am J Clin Pathol 137:825-830. doi: 10.1309/AJCPICNFG7UCES1S
19. Jaskowski TD, Schroder C, Martins TB, Mouritsen CL, Litwin CM, Hill HR (1996) Screening for antinuclear antibodies by enzyme immunoassay. Am J Clin Pathol 105:468-473
20. Homburger HA, Cahen YD, Griffiths J, Jacob GL (1998) Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods. Arch Pathol Lab Me 122:993-999
21. Maguire GA, Ginawi A, Lee J, Lim AY, Wood G, Houghton S, Kumararatne DS, Gaston HJ (2009) Clinical utility of ANA measured by ELISA compared with ANA measured by immunofluorescence. Rheumatology (Oxford) 48:1013-1014. doi: 10.1093/rheumatology/kep137
22. American College of Cardiology(2009) Position statement. Methodology of testing for antinuclear antibodies, 2009. Available from: http://www. rheumatology.org. Accessed 17 June 2010